Related Experiment Video
Updated: May 25, 2026
06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Smoking: effects on multiple sclerosis susceptibility and disease progression
Therapeutic Advances in Neurological Disorders
|January 26, 2012
Summary
Smoking significantly increases the risk of developing multiple sclerosis (MS) and accelerates disease progression. Smokers face a 1.5 times higher risk compared to non-smokers, with potential gene-environment interactions.
Area of Science:
- Neurology
- Environmental Health
- Genetic Epidemiology
Background:
- Multiple sclerosis (MS) etiology involves complex genetic and environmental factors.
- Cigarette smoking is increasingly recognized as a significant environmental risk factor for MS.
- Existing research suggests smoking impacts both MS susceptibility and disease advancement.
Purpose of the Study:
- To review and synthesize current evidence on the association between smoking and multiple sclerosis.
- To examine the influence of smoking on MS risk and disease course.
- To discuss potential causal links and interactions with genetic and other environmental factors.
Main Methods:
- Literature review of epidemiological studies and relevant research.
- Analysis of data on smoking prevalence and MS incidence.
- Examination of studies investigating gene-environment interactions in MS.
Main Results:
- Smokers exhibit approximately 1.5 times higher relative risk for MS development compared to non-smokers.
- Evidence indicates smoking is associated with more rapid disease progression in MS patients.
- Potential interactions between smoking, genetic predisposition, and other environmental exposures are highlighted.
Conclusions:
- Cigarette smoking is a confirmed environmental risk factor for multiple sclerosis.
- Smoking cessation may be a crucial modifiable factor for MS prevention and management.
- Further research is warranted to elucidate the causal mechanisms and interaction pathways.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.